COVID-19 mortality in Lombardy: the vulnerability of the oldest old and the resilience of male centenarians.


Journal

Aging
ISSN: 1945-4589
Titre abrégé: Aging (Albany NY)
Pays: United States
ID NLM: 101508617

Informations de publication

Date de publication:
12 08 2020
Historique:
received: 18 06 2020
accepted: 21 07 2020
pubmed: 14 8 2020
medline: 12 9 2020
entrez: 14 8 2020
Statut: ppublish

Résumé

Italy was the first European nation to be affected by COVID-19. The biggest cluster of cases occurred in Lombardy, the most populous Italian region, and elderly men were the population hit in the hardest way. Besides its high infectivity, COVID-19 causes a severe cytokine storm and old people, especially those with comorbidities, appear to be the most vulnerable, presumably in connection to inflammaging. In centenarians inflammaging is much lower than predicted by their chronological age and females, presenting survival advantage in almost all centenarian populations, outnumber males, a phenomenon particularly evident in Northern Italy. Within this scenario, we wondered if: a) the COVID-19 mortality in centenarians was lower than that in people aged between 50 and 80 and b) the mortality from COVID-19 in nonagenarians and centenarians highlighted gender differences.We checked COVID-19-related vulnerability/mortality at the peak of infection (March 2020), using data on total deaths (i.e. not only confirmed COVID-19 cases). Our conclusion is that excess mortality increases steadily up to very old ages and at the same time men older than 90 years become relatively more resilient than age-matched females.

Identifiants

pubmed: 32788424
doi: 10.18632/aging.103872
pii: 103872
pmc: PMC7467374
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

15186-15195

Références

J Gerontol A Biol Sci Med Sci. 2014 Jun;69 Suppl 1:S4-9
pubmed: 24833586
Cell Death Differ. 2019 Sep;26(9):1845-1858
pubmed: 30622304
Exp Gerontol. 2002 Oct-Nov;37(10-11):1283-9
pubmed: 12470842
J Gerontol A Biol Sci Med Sci. 2019 Apr 23;74(5):600-607
pubmed: 29955888
Front Immunol. 2017 Aug 15;8:982
pubmed: 28861086
Aging Clin Exp Res. 2008 Apr;20(2):91-102
pubmed: 18431075
Cytokine Growth Factor Rev. 2020 Jun;53:33-37
pubmed: 32389499
Mech Ageing Dev. 2007 Jan;128(1):92-105
pubmed: 17116321
Exp Gerontol. 2019 Feb;116:80-85
pubmed: 30590122
Cell Syst. 2020 Jul 22;11(1):11-24.e4
pubmed: 32619549
Annu Rev Nutr. 2018 Aug 21;38:329-356
pubmed: 29852087
BMJ Open. 2018 Feb 8;8(2):e019250
pubmed: 29439076
Biochem Soc Trans. 2003 Apr;31(2):457-61
pubmed: 12653662
Cell Metab. 2016 Jun 14;23(6):1022-1033
pubmed: 27304504
Immun Ageing. 2020 May 21;17:13
pubmed: 32457811
Lancet. 2020 Apr 11;395(10231):1225-1228
pubmed: 32178769
Front Med (Lausanne). 2018 Mar 12;5:61
pubmed: 29662881
Aging (Albany NY). 2020 May 29;12(10):9959-9981
pubmed: 32470948
Nat Med. 2019 Dec;25(12):1843-1850
pubmed: 31806903
Cell. 2014 Nov 6;159(4):709-13
pubmed: 25417146
BMC Neurol. 2016 Apr 21;16:52
pubmed: 27098177
Science. 2020 May 1;368(6490):473-474
pubmed: 32303591
Semin Immunol. 2018 Dec;40:83-94
pubmed: 30501873
Ageing Res Rev. 2013 Mar;12(2):685-98
pubmed: 22353383
Ageing Res Rev. 2020 Sep;62:101091
pubmed: 32454090
Nat Med. 2019 Dec;25(12):1822-1832
pubmed: 31806905
Semin Immunol. 2018 Dec;40:1-5
pubmed: 30392751
Mech Ageing Dev. 2017 Jul;165(Pt B):68-74
pubmed: 28461103
Eur J Immunol. 2001 Aug;31(8):2357-61
pubmed: 11500818
Nat Commun. 2020 Feb 6;11(1):751
pubmed: 32029736
Circ Res. 2018 Sep 14;123(7):745-772
pubmed: 30355083
Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):E832-E840
pubmed: 29311321
J Am Coll Cardiol. 2020 Mar 3;75(8):968-979
pubmed: 32130932
Aging (Albany NY). 2015 Dec;7(12):1159-70
pubmed: 26678252

Auteurs

Gabriella Marcon (G)

DAME, University of Udine, Udine, Italy.
Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), Trieste, Italy.
Department of Medical Surgical and Health Sciences, University of Trieste, Trieste, Italy.

Mauro Tettamanti (M)

Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Giorgia Capacci (G)

Directorate for Social Statistics and Population Census, Istat, Italy.

Giulia Fontanel (G)

Department of Medical Surgical and Health Sciences, University of Trieste, Trieste, Italy.

Marco Spanò (M)

Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), Trieste, Italy.

Alessandro Nobili (A)

Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Gianluigi Forloni (G)

Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Claudio Franceschi (C)

Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
Laboratory of Systems Medicine of Healthy Aging, Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH